Scientists and public health experts built the COVID-19 pandemic response on years of experience navigating infectious disease outbreaks. Although lateral flow immunoassays have been central to ...
The global lateral flow assay (LFA) market is projected to grow from USD 10.01 billion in 2024 to USD 15.42 billion by 2030, driven by increasing demand for point-of-care testing and the rising ...
Lateral flow assays (LFAs), such as the COVID-19 rapid test, are powerful devices to rapidly detect a protein’s presence or absence. This assay is so easy to perform that it enables at-home testing, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results